Rapid elimination of a high-titered F VIII inhibitor by high dose recombinant F VIII combined with high dose immunoglobulin infusion.
Mauz-Korholz
C
C
Korholz
D
D
Gobel
U
U
D000906:Antibodies / Q000276:immunology; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use
D000906:Antibodies; D016756:Immunoglobulins, Intravenous; D011994:Recombinant Proteins; D005169:Factor VIII